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Background: Treatment of severe osteoarthritis (OA) in relatively young patients is challenging. Although
successful, total knee prosthesis has a limited lifespan, with the risk of revision surgery, especially in
active young patients. Knee joint distraction (KJD) provides clinical beneﬁt and tissue structure modi-
ﬁcation at 1-year follow-up. The present study evaluates whether this beneﬁt is preserved during the
second year of follow-up.
Methods: Patients included in this study presented with end-stage knee OA and an indication for total
knee replacement (TKR); they were less than 60 years old with a VAS pain 60 mm (n ¼ 20). KJD was
applied for 2 months (range 54e64 days) and clinical parameters assessed using the WOMAC ques-
tionnaire and VAS pain score. Changes in cartilage structure were measured using quantitative MRI,
radiography, and biochemical analyses of collagen type II turnover (ELISA).
Results: Average follow-up was 24 (range 23e25) months. Clinical improvement compared with baseline
(BL) was observed at 2-year follow-up: WOMAC improved by 74% (P < 0.001) and VAS pain decreased by
61% (P < 0.001). Cartilage thickness observed by MRI (2.35 mm (95%CI, 2.06e2.65) at BL) was signiﬁcantly
greater at 2-year follow-up (2.78 mm (2.50e3.09); P ¼ 0.03). Radiographic minimum joint space width
(JSW) (1.1 mm (0.5e1.7) at BL) was signiﬁcantly increased at 2-year follow-up as well (1.7 mm (1.1e2.3);
P ¼ 0.03). The denuded area of subchondral bone visualized by MRI (22% (95%CI, 12.5e31.5) at BL) was
signiﬁcantly decreased at 2-year follow-up (8% (3.6e12.2); P ¼ 0.004). The ratio of collagen type II syn-
thesis over breakdown was increased at 2-year follow-up (P ¼ 0.07).
Conclusion: Clinical improvement by KJD treatment is sustained for at least 2 years. Cartilage repair is
still present after 2 years (MRI) and the newly formed tissue continues to be mechanically resilient as
shown by an increased JSW under weight-bearing conditions.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a slowly progressive joint disorder clini-
cally characterized by pain, stiffness, and functional disabilities.
Structural characteristics comprise cartilage damage and loss,
changes in subchondral bone, and secondary synovial inﬂamma-
tion. These tissue changes are only partially associated with the
clinical characteristics1e3.
The incidence of OA is increasing, due to an aging population
and a rise of obesity4,5. There is no cure for OA, and the ﬁrst step inF.P.J.G. Lafeber, Rheumatology
feber).
s Research Society International. Pcurrent treatment is conservative, predominantly focused on pain
relief, minimizing functional disability, and limiting progression of
structural joint changes. New treatments include cell trans-
plantation techniques and disease modifying OA drugs (DMOADs)6.
When conservative treatment fails and joint preserving surgery is
not or no longer indicated, total knee replacement (TKR) of the
affected joint is recommended. It is questionable, however,
whether all options are routinely considered before replacement
surgery is performed7e9.
TKR is a ﬁnal option and although expensive, considered effec-
tive in relieving pain and regaining function10,11. The total number
of TKRs is increasing, as is the rate of revisions. It is remarkably that
over 40% of all knee replacements and up to 44% of all total knee
revisions are performed in patients 65 years of age11, considering
the known problems of limited lifespan of TKRs. This constitutes aublished by Elsevier Ltd. All rights reserved.
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tive treatment strategies for end-stage knee OA is necessary in
order to preserve a patient’s joint.
For certain disease speciﬁc indications, joint preserving surgery
is an option; these include arthroscopic debridement, subchondral
bone stimulation, osteotomy, and more recently, knee joint
distraction (KJD). Joint distraction has been effectively applied in
ankle OA with prolonged clinical beneﬁt and indications of tissue
structure modiﬁcation14e16; there has also been a report of clinical
beneﬁt in the hip, published already years ago17, although this has
not been further explored. Recently, joint distraction was applied
for severe end-stage knee OA, and a study by Deie M et al. reported
positive clinical results with the use of hinged knee distraction over
time18. These treatment approaches are discussed in detail in a
review that was recently published by our group19.
In 2006, our group started the ﬁrst prospective evaluation of
knee distraction in 20 patients with severe end-stage OA, whowere
considered for a TKR. In addition to evaluating clinical beneﬁt, we
also measured tissue structural repair using various imaging and
biochemical markers. Analysis of the 1-year follow-up revealed
positive clinical beneﬁt and signs of cartilage repair20. This paper
examines whether these beneﬁcial effects are preserved over the
second year of follow-up.
Materials and methods
Patient selection
Twenty-three successive patients with end-stage OA (average
age 49 1 years, range 32e57 years), indicated for TKR surgery due
to persistent loss of function and pain, not adequately responding
to conventional treatments were selected at the Department of
Orthopedics, University Medical Center Utrecht. In short, inclusion
criteria were age <60 years, Visual Analogue Scale (VAS) of pain
60mm, and radiographic signs of primarily tibio-femoral OA joint
damage. Exclusion criteria were severe symptoms in both knees,
primary patella-femoral OA, a history of inﬂammatory or septic
arthritis, severe knee malalignment (>10) requiring surgical
correction and inability to cope with an external ﬁxator for 2
months. Patients had been referred from peripheral hospitals for a
second opinion because the patient refused the indicated TKR for
personal reasons mostly related to young age. Detailed clinical
history of all patients has been previously described20. Of the 23
successively selected patients, three were excluded: one based on
bilateral OA; one because of remaining metal in the knee after
anterior cruciate ligament (ACL) reconstruction; and one withdrew
the informed consent directly after treatment. The 20 included
patients had predominantly medial compartmental OA (n ¼ 18;
most affected compartment (MAC) is medial), stable joints (despite
three previous ACL ruptures), and an average K&L grade of 3
(Table I). Baseline (BL) characteristics of individual patients are
given in Table I. This study was approved by the medical ethics
review committee of the University Medical Center Utrecht (No.04/
086), and all patients gave written informed consent.
Distraction method
The distraction method was applied as previously described by
Intema et al.20. In short, an external ﬁxation frame (Fig.1) consisting
of two monotubes with internal coil springs was placed, bridging
the knee joint. Each monotube was ﬁxed to two bone pins on each
end and, in stages, distracted for 5 mm (conﬁrmed by X-ray). After
instructions about pin site care, daily exercise, and physical therapy,
the patients were discharged from the hospital. Patients were
allowed and encouraged to load the distracted joint with fullweight-bearing capacity, supported with crutches. In case of su-
perﬁcial (skin) pin tract infections, treatment with oral antibiotics
for 5e7 days was provided (Flucloxacillin). Every 2 weeks the pa-
tients returned to the hospital and the monotubes were tempo-
rarily removed. The knee was bent, for 3e4 h, in a continuous
passive motion device, with pain at the pin sites determining the
maximum degree of ﬂexion; on average, 25 (15e80) ﬂexion and
full extension was reached. The monotubes were replaced and
sufﬁcient distraction was conﬁrmed by X-ray examination and
adjusted if needed.
After 2 months (average duration 60 days, range 54e64 days),
the tubes and pins were surgically removed and patients went
homewithout imposed functional restrictions. After both surgeries,
patients were treated with acetaminophen and NSAID as needed,
according to the standard analgesia protocol of the UMCU. Upon
discharge, pain medication, along with daily exercise and physical
therapy, were regulated by the patient and not documented.
Follow-up
Patients visited the outpatient clinic twice before treatment (BL)
and at 3 and 6 months, and subsequently every 6 months post-
treatment. At these time points the WOMAC questionnaire21 and
VAS pain score were assessed. For evaluation of structural improve-
ment, blood andurine sampleswere collected at BL and at six,12 and
24 months after distraction therapy and stored at 80C. Standard-
ized weight-bearing X-ray images according to the knee images
digital analyses (KIDA) protocol22 andMRIs according to the Eckstein
protocol23 were taken at BL, and at 1 and 2 years of follow-up.
Clinical outcome
To score clinical improvement, the WOMAC (version 3.0,
normalized to a 100-point scale for total and subscales; 100 being
the best score) was used as primary outcome parameter. The sec-
ondary clinical outcome parameter was the VAS pain score (0e
100 mm; “0” meaning no pain). To identify actual responders, we
used the Osteoarthritis Research Society International (OARSI)
deﬁned OARSI-OMERACT responder criteria, validated for drug-
therapies24 and TKR25 in case of diagnosed knee OA.
Structural outcome
Quantitative MRI analysis
MRI acquisition was performed with a 1.5 T Philips Achieva,
using a 3D spoiled gradient recalled (SPGR) sequence with fat
suppression (repetition time 20 ms; echo time 9 ms; ﬂip angle 15;
slice thickness 1.5 mm; in-plane resolution 0.3125  0.3125 mm),
which has been previously validated for the purpose of quantitative
measurement of cartilage thickness and volume23. Coronal images
were used to segment the tibio-femoral cartilage plates and bone
surface, including denuded areas. The operator (SC) and quality
control reader (FE) were blinded to the sequence of the BL and the
1-year follow-up images19; 2-year follow-up images were
segmented independently, without reference to the BL or 1-year
follow-up images, in order to exclude reading bias, and prevent
overestimation of results. Cartilage parameters in the medial and
the lateral compartment were computed using custom software
(Chondrometrics GmbH., Ainring, Germany). The primary struc-
tural outcomes were cartilage thickness over the total subchondral
bone area (ThCtAB; cartilage thickness with areas of denuded bone
included, counting as 0 mm thickness) and the percentage of
denuded subchondral bone area (dABp)26. The secondary structural
outcome parameter was cartilage thickness over cartilaginous area
of subchondral bone (ThCcAB; cartilage thickness with areas of
Table I
BL characteristics of all patients
WOMAC X-ray MRI (MAC)
# Gender Affected
knee
MAC Age at
surgery
(yrs)
K&L Total Pain Stiffness Function Min JSW
MAC (mm)
Mean JSW
MAC (mm)
Mean JSW
LAC (mm)
ThCtAB
(mm)
dABp
(%)
ThCcAB
(mm)
1 M L M 50 4 42.5 40.6 75.0 39.9 0.00 0.00 6.00 1.5 42.7 2.5
2 F L M 49 1 28.7 33.3 18.8 27.0 3.87 4.15 4.55 2.9 1.2 2.9
3 M L L 32 2 20.3 22.9 12.5 20.2 1.12 7.19 4.49 3.2 0.7 3.2
4 M R M 51 3 31.9 37.5 37.5 29.8 0.45 2.06 8.38 1.8 39.8 2.9
5 M R M 51 3 62.9 60.4 62.5 63.7 0.25 2.90 6.72 2.4 32.7 3.3
6 F L M 51 2 25.0 25.0 25.0 23.4 1.00 2.67 6.26 2.5 0.0 2.5
7 M L M 51 3 46.1 52.1 43.8 44.6 0.00 1.31 10.24 1.8 42.8 2.9
8 F R M 45 3 53.4 43.8 43.8 57.1 0.33 2.07 6.15 2.0 27.3 2.7
9 M L M 50 3 53.0 62.5 50.0 54.4 0.00 1.31 6.17 1.5 48.1 2.5
10 M L M 48 3 72.9 47.9 50.0 39.7 2.79 5.54 8.97 3.0 16.8 3.7
11 F L M 45 3 70.3 68.8 75.0 70.2 0.49 2.40 5.27 1.8 40.1 2.8
12 F L M 53 3 52.6 52.1 50.0 51.4 0.30 2.80 7.41 1.8 41.8 3.1
13 F L M 45 3 51.5 52.1 50.0 51.4 0.48 2.47 8.51 2.9 0.0 2.9
14 F R M 44 1 27.2 20.8 25.0 29.3 2.95 3.41 6.47 3.2 0.0 3.2
15 M L M 55 3 51.7 52.1 50.0 51.8 0.20 2.56 6.75 2.8 5.0 3.0
16 F R M 57 2 55.6 62.5 62.5 53.0 0.32 2.15 7.91 3.0 0.0 3.0
17 M R M 52 3 39.7 47.9 25.0 38.7 0.00 0.69 6.57 1.9 39.4 3.1
18 M R L 39 4 55.4 62.5 50.0 53.9 3.62 3.89 7.72 1.4 54.0 2.9
19 M R M 52 2 42.7 45.8 56.3 40.5 0.77 2.90 7.30 3.1 6.2 3.3
20 F R M 50 1 15.5 12.5 25.0 15.4 2.65 3.56 4.13 2.5 1.4 2.6
Ratio 11/9
(M/F)
11/9
(L/R)
18/2
(M/L)
Mean  S.E.M. 49  1 3 44.9  3.6 45.2  3.5 14.4  4.0 42.8  3.4 1.1 þ 0.3 2.8  0.4 6.8  0.3 2.4  0.1 22.0  4.5 2.9  0.1
Gender: M¼male, F¼ female; affected knee: L¼ left, R¼ right; M¼medial, L¼ lateral; K&L¼ Kellgren and Lawrence grade;WOMAC:Western Ontario andMcMaster Universities Osteoarthritis index version 3,0 score range 0e
100, 0 being worst 100 being best; JSWMAC: joint space widthMAC, min¼minimal; JSW LAC: joint space width least affected compartment. ThCtAB¼ cartilage thickness over total subchondral bone area. dABp¼ percentage of
denuded subchondral bone area. ThCcAB ¼ cartilage thickness over cartilaginous area of subchondral bone.
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Fig. 1. Fixateur externe used for KJD. Two monotubes are ﬁxated with eight bone pins
and distracted for 5 mm. Internal coil springs allow 2e3 mm axial compression, which
still prevents the cartilage from mechanical load during treatment period. Distraction
was performed for 8 weeks.
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reproducibility of this type of analyses has been published before in
detail27e29.
Radiographic analysis
Because MR images are taken unloaded (non weight-
bearing), additional X-rays were taken of weight-bearing pa-
tient joints to provide indirect information on the resilience of
the cartilaginous tissue. Fully standardized, weight-bearing,
semi-ﬂexed posterioreanterior radiographic views were ac-
quired for evaluation by KIDA software22. KIDA analysis is a fully
mathematical method independent of subjective reader inter-
pretation. Images were analyzed blinded to acquisition order
and patient characteristics, and collects every time point inde-
pendently. It thus provides an objective method for analyzing
minimal and mean joint space width (JSW) in the MAC, and
mean JSW for the whole joint. Subchondral bone density was
analyzed using an aluminum step wedge as a reference and is
expressed in mm Aluminum (Al) equivalents22.
Biomarker analysis
To obtain indirect information on the cartilage (and bone)
metabolism, and the quality of newly formed tissue, collagen type
II synthesis and breakdown activity were analyzed in serum and
urine samples by use of PIIANP ELISA kit (Millipore, EZPIIANP-
53K) and CTX-II ELISA kit (Immunodiagnostic systems, Urine
CartiLaps EIA; corrected for urine creatinine), respectively.Samples were analyzed in duplicate, and longitudinal samples for
each time point of a patient were analyzed in the same assay
plate. Average intra-plate and inter-plate variability were 3.8%
and 10.9%, respectively.
Statistical methods
Non-parametric statistics (two-sided paired test) were used for
all parameters, to evaluate whether the follow-up values signiﬁ-
cantly differed from the BL values. Double BL values were averaged.
Spearman correlation coefﬁcients and unpaired non-parametric
comparison of dichotomized data were used to relate/compare
longitudinal changes over 2 years for different outcome parame-
ters. Means and 95% conﬁdence intervals (95%CI) are given for the
20 patients; a P  0.05 was considered a statistically signiﬁcant
difference. There were nomissing data. For all statistical tests, IBM
SPSS Statistics version 20.0.0 was used.
Results
Adverse events
As result of treatment with the external ﬁxation frame30, 17 pa-
tients suffered from a pin tract infection, all adequately treatedwith
antibiotics (Flucloxacillin), and no further complaints reported. No
deep vein thromboembolismwas diagnosed. Two patients suffered
from a pulmonary embolism, adequately treated with oral anti-
coagulates (Sintrom) for 6 months. Limited ﬂexion limitation was
observed directly after treatment (31.6 of ﬂexion, (95%CI 43.9
to 19.2)), within 6 months the patients recovered to acceptable
levels (7.2 of ﬂexion, (15.2 to 1.1)) and ﬂexion range fully
normalizedwithin 1-year follow-up (þ2.9 of ﬂexion, (3.3 to 9.1)).
Clinical beneﬁt
A quick clinical improvement, based on the total WOMAC index,
was already observed at 3 months reaching a plateau within 6
months, and was sustained until 2-year post-treatment [Fig. 2(A)].
The relative improvement from BL to 1- and 2-year follow-up was
70% (95%CI 38.6e152.5%) and 74% (45.8e161.6), respectively, both
P < 0.001 compared to BL. Also, the individual components of the
WOMAC score [pain, stiffness, and function; dotted lines in
Fig. 2(B)] all improved statistically signiﬁcant (all P < 0.005 at each
time point) in a similar manner.
VAS pain decreased almost instantly (at 3 months) and stayed
low through the 2-year follow-up, which is a relative decrease in
comparison to BL of 58% (95%CI 73.8 to 39.3) at 1 year
and 61% (78.3 to 39.3) at 2 years post-treatment.
On the individual level, 15 patients (75%) could be designated as
actual clinical responders according to the OARSI-OMERACT
responder criteria24. Responders are deﬁned as an increase of
>50% in WOMAC pain OR function with >20 points of improve-
ment in either category; or an increase of>20% ofWOMC pain AND
function with 10 points improvement in each category. Moreover,
10 patients at 1-year follow-up and nine patients at 2-year follow-
up achieved an increase of >50% in WOMAC pain AND function,
with at least 20 points of improvement for both categories.
Structural outcome
Quantitative MRI
Figure 3(A) shows representative images of a patient, clearly
indicating an increase in cartilage thickness over time in theMAC of
the knee joint while the least affected compartment remained
unchanged. Quantiﬁcation of these MRIs showed a strong increase
Fig. 2. Clinical evaluation of KJD. Clinical evaluation presented by the total WOMAC (version 3.0; 100 being the best score, 0 being the worst score) and VAS pain score (100 mm
most severe pain and 0 mm meaning no pain) with a follow-up of 2 years, mean  95%CI are given in Fig. 2(A). In Fig. 2(B) the mean of the three individual components of the
WOMAC score are presented (statistically signiﬁcant improvement at all time points for all three subscales). An asterisk indicates a statistical signiﬁcance of P-value <0.001
compared to BL. For the three WOMAC sub scores all values were statistically signiﬁcant improved compared to BL (P < 0.005).
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0.24e1.22; P ¼ 0.002) from BL to 1-year follow-up, and 0.4 mm
(0.06e0.83; P ¼ 0.030) from BL to 2-year follow-up [Fig. 3(B)].
After distraction, on average, the subchondral bone area that
was denuded (dABp) in theMAC decreased from 22% (12.5e31.5) at
BL to 5% (0.4e8.6; P¼ 0.001) and 8% (3.6e12.2; P¼ 0.004) at 1- and
2-year follow-up, respectively [P-values compared to BL; Fig. 3(C)].
No statistically signiﬁcant differences in dABp were identiﬁed be-
tween 1- and 2-year follow-ups.
Moreover, the mean ThCcAB did not change over time
[Fig. 3(D)], implying that newly formed cartilaginous tissue (ﬁlling
in of denuded areas) was not at the expense of thickness of existing
cartilage pre-treatment.
In the least affected compartments no clear changes in cartilage
structure were observed and no statistically signiﬁcant changes at
1- and 2-year follow-up were found compared to BL (data notFig. 3. Structural changes by MRI. Representative images of single slides (all same patient) a
analysis of cartilage of the MAC are presented in Fig. 3(BeD). ThCtAB ¼ cartilage thickness ov
ThCcAB ¼ cartilage thickness over cartilaginous area of subchondral bone. An asterisk indi
dicates a P-value<0.002.shown). Changes calculated for the whole joint, showed an
improvement in cartilage structure as well, which was most
evident and statistically signiﬁcant for dABp (Table II).
Radiographic analysis
Radiographic analysis corroborated the MRI data. The minimum
JSW in the MAC showed a statistically signiﬁcant gradual increase
over the 2 years: 51% (0.55mm, 95%CI 0.09e1.02; P¼ 0.03) at 1 year
and 59% (0.57mm, 0.09e1.06; P¼ 0.03) at 2 years (Fig. 4). Themean
JSW of the MAC shows a similar trend, albeit less striking, with an
increase of 24% (0.66 mm, 0.06e1.26; P ¼ 0.03) and 21%
(0.36 mm, 0.13 to 0.85; P ¼ 0.11) at 1 and 2 years, respectively. A
tendency towards a gradual increase in JSW was also observed at
the least affected compartment, although the change was not sta-
tistically signiﬁcant (Fig. 4). Averaged JSW of the whole joint also
increased (Table II), and subchondral bone density normalized aftert BL, 1 and 2 years after treatment are given in Fig. 3(A). Mean  95%CI quantitative MRI
er total subchondral bone area. dABp ¼ percentage of denuded subchondral bone area.
cates a statistical signiﬁcance of P-value <0.05 compared to BL, a double asterisks in-
Table II
Primary structural outcome parameters from quantitative MRI and X-ray analyses of the whole joint (all compartments)
Whole joint
BL 1 yr 2 yrs P < (0e1) P < (0e2) P < (1e2)
MRI ThCtAB (mm) 3.3 (3.1e3.4) 3.6 (3.4e3.8) 3.5 (3.3e3.7) 0.005 0.040 0.212
MRI dABp (%) 11.3 (6.6e16.0) 2.5 (0.4e4.6) 4.3 (2.0e6.6) 0.001 0.002 0.064
MRI ThCcAB (mm) 3.6 (3.4e3.8) 3.7 (3.5e3.9) 3.6 (3.4e3.8) 0.470 0.590 0.350
MRI VC (mm3) 3018 (2669e3368) 3316 (2899e3732) 3263 (2845e3680) 0.100 0.020 0.232
X-ray JSW (mm) 4.8 (4.3e5.3) 5.2 (4.7e5.7) 5.3 (4.4e5.8) 0.057 0.053 0.809
Measurements at BL, 1 and 2 years after KJD treatment, including two-sided p-values of delta 0e1 year, delta 0e2 year and delta 1e2 year. ThCtAB ¼ cartilage thickness over
total subchondral bone area. dABp ¼ percentage of denuded subchondral bone area. ThCcAB ¼ cartilage thickness over cartilaginous area of subchondral bone. VC ¼ cartilage
volume in mm3; and JSW (mm) on radiographs according to KIDA measurements.
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follow-up (data not shown).
The increase in radiographic mean JSW in the MAC over 2 years
demonstrated a good linear correlation with an increase in ThCtAB
(r ¼ 0.67, P < 0.000) and an inverse correlation with a decrease in
dABp on MRI over 2 years (r ¼ 0.66, P ¼ 0.004).
Biomarker analysis
From 6 months until 2 years of follow-up, a tendency for an
increase in collagen type II synthesis marker PIIANP (from 1811 ng/
mL (95%CI, 1645e1977) to 1856 ng/mL (1642e2071); þ3% (8 to
18); P ¼ 0.69), and a clear decrease in collagen type II breakdown
marker CTXII (from 329 ng/mmol creat (249e410) to 229 ng/mmol
creat (188e269); 31% (37 to 1); P ¼ 0.006) was found. When
expressed as a ratio of PIIANP/CTXII for each patient at each time
point, an increase of collagen type II synthesis of 25% (18e103)
(from 7.5 (5.2e9.9) to 9.4 (7.7e11.1); P ¼ 0.07) at 2-year follow-up
was calculated.
Relation between clinical beneﬁt and structural changes
No clear statistically signiﬁcant correlations between the change
in clinical parameters and the change in structural parameters wereFig. 4. JSW (KIDA measurement). Representative standardized X-rays (all same pa-
tient) at BL, 1 and 2 years after treatment are given in Fig. 4(A). Mean  95%CI
quantitative X-ray analysis of both the MAC and least affected compartment are pre-
sented in Fig. 4(B). The upper dotted line represents the mean JSW of the LAC (least
affected compartment), the middle dotted line the mean JSW of the MAC and the
continuous bottom line the minimal JSW of the MAC. An asterisk indicates a statistical
signiﬁcance of P-value <0.05 compared to BL.observed in this small group of patients. There was a slight corre-
lation between the decrease in VAS pain score and the change in
subchondral bone density at 2-year follow-up (r¼ 0.31, P¼ 0.06); at
1-year follow-up the correlation was signiﬁcant (r ¼ 0.29, P ¼ 0.05)
(data not shown).Discussion
The present prospective open uncontrolled study demonstrates
that joint distraction results in substantial clinical and structural
improvement in relatively young patients with end-stage knee OA
in such a manner that the original planned total knee prosthesis
could be postponed for at least 2 years in all patients. The signiﬁ-
cant reduction of pain and signiﬁcant improvement of function is
sustained for at least 2 years, and further follow-up is ongoing.
Assuming that prolonged beneﬁt of the treatment of these rela-
tively young and active patients, may lead to prevention of revision
surgery in time.
Distraction therapy might be perceived as a burdensome
treatment for patients because they experience 2 months of joint
stiffness and potential pin tract pain/infection during the distrac-
tion period. Despite these side effects, the clinical beneﬁt appeared
worth the “investment”, as reported by all patients. Moreover,
alternative surgical interventions such as osteotomy are at least as
burdensome.
One of the most impressive and maybe unexpected results was
that the denuded bone areas (dABp) were diminished, and ﬁlled
with tissue that has the same signal intensity as cartilage, when
estimated by MR imaging. This challenges the dogma that intrinsic
cartilage repair is not possible. It is difﬁcult to envision that this
effect is solely due to an increased matrix synthesis of resident
chondrocytes. As such it is postulated that resident mesenchymal
stem cells (MSCs) in the joint31,32 are important for intra-articular
repair activity. Contribution appears to consist of metabolic stim-
ulation of existing chondrocytes or differentiation in an osteogenic
manner into new chondrocytes. Hydrostatic dynamic pressure (1e
10 kPa), as measured intra-articular during knee and ankle joint
distraction33 when applied in vitro, can stimulate MSCs in co-
culture with cartilage, leading to cartilage matrix synthesis34.
Filling up denuded bone areas contributes to the mechanical
competence of the cartilage, as demonstrated by increased JSW
under weight-bearing conditions (X-ray). After 2 years of unre-
stricted loading/mobility, this newly formed tissue is still present,
as seen on MR images of the participants, and has functional ca-
pabilities. No other treatment at present can induce and preserve
such changes in cartilage quantity and morphology.
We can only speculate on the quality of the newly formed
cartilaginous tissue; it might be, in part, ﬁbrocartilaginous tissue.
Compositional MRI acquisitions, such as dGEMRIC, which could
potentially provide clues on the biochemical and structural
composition of the newly formed tissue, were not included in the
K. Wiegant et al. / Osteoarthritis and Cartilage 21 (2013) 1660e16671666study protocol, to keep acquisition within a clinically manageable
time frame. The positive ratio for collagen type II synthesis (PIIANP/
CTXII) is suggestive of hyaline (collagen type II-containing type of
cartilage) formation. Onemust keep inmind that CTX-II, in addition
to cartilage breakdown, also represents bone turnover35. In that
respect it should be noticed that normalization of subchondral
bone by ankle distraction over a period of 2 years was demon-
strated by CTanalyses14. As such the changes in CTX-II might also be
caused by subchondral bone changes.
Some limitations of this treatment are acknowledged. Seventeen
out of 20 patients (85%) suffered from a pin tract infection, which is
a common and well-known side effect of treatment with an
external ﬁxation frame6,30. All were adequately treated with anti-
biotics, and we are aware of latent risk of infection, speciﬁcally
because these patients are at high risk of prosthesis surgery in the
future. It is expected that the increased time between removal of
the external ﬁxation frame and potential subsequent total joint
surgery will decrease the risk of infection. Accurate registry of
follow-up data will demonstrate if the interval between KJD treat-
ment and TKR is sufﬁcient for preventing infections. Further follow-
up is also needed in order to investigate the duration of the clinical
and structural effects from KJD; the long-term (7 year) follow-up
results of ankle joint distraction are good and promising16.
Furthermore, the 2 years follow-up MRI scans were segmented
independently, without reference to BL or 1-year follow-up images
in order not to introduce a reading bias and with that over-
estimation of the results. This in contrast to the MRI analysis for BL
and 1-year follow-up that were segmented pair-wise, without
knowledge of sequence. The knowledge of the good effects at
1-year would have led to an overestimation of the results in case
2-years segmentation would have been performed pair-wise with
BL again. So, the presented data might be an underestimation of the
actual structural improvement. Blinding to sequence for X-ray
analysis is not an issue as it concerns a fully mathematical reading
which is independent of subjective knowledge on images from the
same joint at other time points. Irrespectively, analyses were per-
formed fully blinded. Finally, this study unfortunately lacks a
proper control group. However, designating this group presents
two challenges. First, a control group is ethically sensitive, as there
are no alternatives for these patients, and they would undergo an
unnecessary (surgical) intervention or would bewithheld adequate
treatment for an unnecessary period of time. Second, the results of
this study (tissue structure repair with clinical beneﬁt) were un-
knownwhen the study was designed, making selection of a control
group complex. In order to investigate the beneﬁt of KJD safely and
effectively, this study was designed as an uncontrolled prospective
follow-up study. Clearly future studies should include comparators
such as total knee prosthesis (for clinical outcome) or high tibial
osteotomy (for tissue structure modiﬁcation as well).
A clear correlation between the clinical improvement and
structural repair tissue repair could not be demonstrated in this
study. This indicates that pain sensation is not obviously related to
structural changes. Overall, the best relationship between the
clinical and structural parameters was identiﬁed for pain and bone
changes. For example, a correlation between the presence/absence
of bone marrow lesions (BMLs) and the VAS pain score is
described36,37. Unfortunately, in the present study, MRI sequences
enabling proper subchondral bone marrow evaluation were not
included. Moreover, the number of patients limits proper correla-
tion analyses. It would be of interest to study predictors and
duration of outcome, as over time, patients may still require a
prosthesis; the number of patients is too small to properly perform
such an analyses for this study.
In conclusion, this study shows that clinical improvement by
KJD treatment is sustained for at least 2 years and the partially,newly formed cartilage-like tissue is stable and mechanically
effective to the extent that the JSW increases at radiographic ex-
amination under weight-bearing conditions. As a result, KJD can
postpone a TKR for at least 2 years and, assuming prolonged
beneﬁt, possibly prevent revision surgery. Ideally, this new joint
sparing treatment should be further investigated in comparison to,
or in combinationwith, other treatments such as DMOADs and cell-
based therapies6. Next steps for joint distraction should include
prolonged follow-up and randomized controlled trials inwhich KJD
is compared with currently used surgical treatments such as TKR
and osteotomy. This will provide more knowledge on the ‘position’
of KJD as a treatment option for end-stage knee OA for relatively
young patients.
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